Bambusa Therapeutics Statistics
NASDAQ: BBTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
16.00+0.45 (+2.89%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Bambusa Therapeutics by the numbers
Bambusa Therapeutics has a market capitalization of $815.1 million based on 50.94M shares outstanding. With trailing EPS of $-1.73, Bambusa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 0.9% below its 200-day average.
Average daily trading volume is 359.41K shares, or about $5.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BBTX valuation vs. peer median
| Metric | BBTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $815.08M | $759.09M | +7% |
| Avg. volume | 359.41K | 904.98K | -60% |
Peer median across 8 companies: ODTX, PRME, MGTX, IMTX, GLUE, AURA, SLDB, ATTO.
Valuation
- Market cap
- $815.08M
- EPS (TTM)
- $-1.73
- Shares outstanding
- 50.94M
Price and trading
- Previous close
- 15.55
- Open
- 15.46
- Day range
- 15.21 – 16.69
- 52-week range
- 13.60 – 17.65
- Beta
- —
- Volume
- 137.67K
- Average volume
- 359.41K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 815.08M
- Eps
- -1.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.65
- Week52 Low
- 13.60
- Avg Volume
- 359.41K
- Shares Outstanding
- 50.94M
- Ma50
- 16.15
- Ma200
- 16.15
- Pct From52w High
- -9.35%
- Pct From52w Low
- 17.65%